1. Home
  2. BIO vs HSIC Comparison

BIO vs HSIC Comparison

Compare BIO & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$312.40

Market Cap

8.7B

Sector

Industrials

ML Signal

HOLD

Logo Henry Schein Inc.

HSIC

Henry Schein Inc.

HOLD

Current Price

$78.78

Market Cap

9.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIO
HSIC
Founded
1952
1932
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7B
9.1B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
BIO
HSIC
Price
$312.40
$78.78
Analyst Decision
Strong Buy
Hold
Analyst Count
4
14
Target Price
$358.50
$76.29
AVG Volume (30 Days)
184.0K
1.2M
Earning Date
02-12-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.70
EPS
N/A
3.17
Revenue
$2,557,500,000.00
$12,938,000,000.00
Revenue This Year
$1.62
$5.34
Revenue Next Year
$2.26
$3.42
P/E Ratio
N/A
$24.53
Revenue Growth
N/A
3.51
52 Week Low
$211.43
$60.56
52 Week High
$373.69
$82.49

Technical Indicators

Market Signals
Indicator
BIO
HSIC
Relative Strength Index (RSI) 47.12 57.81
Support Level $306.52 $77.53
Resistance Level $328.56 $79.97
Average True Range (ATR) 9.16 2.08
MACD -0.38 -0.05
Stochastic Oscillator 40.11 78.02

Price Performance

Historical Comparison
BIO
HSIC

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About HSIC Henry Schein Inc.

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.

Share on Social Networks: